Moderna Stock Poised For Another Drop After Shaving Nearly $1 …

2 days ago · Drug maker Moderna's stock plunged more than 17% in pre-market trading on Monday after the company slashed its sales outlook by $1 billion.. The company reported …

17%
OFF

Moderna Stock Poised For Another Drop After Shaving Nearly $1 …

2 weeks from now

2 days ago · Drug maker Moderna's stock plunged more than 17% in pre-market trading on Monday after the company slashed its sales outlook by $1 billion.. The company reported …

ibtimes.com

17%
OFF

Moderna Stock Plunges Nearly 17% After Company Lowers 2025 …

2 weeks from now

Moderna now expects 2025 revenue of between $1.5 billion and $2.5 billion, most of which will come in the second half of the year. The majority of those sales will come from Moderna's …

msn.com

$1
OFF

Moderna Stock Poised For Another Drop After Shaving Nearly $1 …

2 weeks from now

2 days ago · The company reported product sales of $3 to $3.1 billion in 2024 but lowered 2025's expected revenue range to $1.5 to $2.5 billion. The company blamed weak demand for its …

moneytimes.com

39%
OFF

Moderna Stock Down 39% In Three Months: Buy The Dip Or Wait?

2 weeks from now

Dec 23, 2024 · Alongside the guidance cut, Moderna also implemented a portfolio prioritization and cost efficiency program to reduce annual R&D expenses and focus on products that are …

yahoo.com

$1
OFF

Moderna Stock Keeps Falling. An Analyst's Downgrade Isn't Helping

2 weeks from now

Sep 13, 2024 · Shares of Moderna fell Friday after taking on steep losses a day earlier on the news that it plans to cut research and development spending by $1.1 billion by 2027.

yahoo.com

$158.82
OFF

Moderna’s Recent Drop: 4 Reasons Bulls See Opportunity

2 weeks from now

Sep 16, 2024 · MRNA stock is coming off two descending triangle breakdowns. The first started at $158.82 and broke down through the flat-bottom support at $115.97 following its Q2 2024 …

nasdaq.com

$1
OFF

Moderna Stock Drops On Plans To Cut $1.1B In R&D Costs - Yahoo …

2 weeks from now

Sep 12, 2024 · Moderna projects fiscal 2025 revenue of between $2.5 billion to $3.5 billion compared to analyst projections of $2.9 billion, and said Thursday that it expects to break even …

yahoo.com

$1
OFF

Moderna Crashes After Slashing Its R&D Budget By $1.1 Billion

2 weeks from now

Sep 16, 2024 · Shares are poised to open at a 10-month low. Moderna stock has dropped off markedly after shooting to a record high in August 2021. ... 1/07/2025 Moderna stock surged …

investors.com

25%
OFF

Moderna Stock Plunges As Vaccine Maker Slashes R&D Budget

2 weeks from now

Sep 12, 2024 · In the release, Moderna also said it anticipates fiscal 2025 revenue to be in the range of $2.5 billion to $3.5 billion and sales to grow at a 25% compound annual growth rate …

kiplinger.com

21%
OFF

Why Moderna Stock Just Crashed 21% - Nasdaq

2 weeks from now

2 days ago · Moderna's (NASDAQ: MRNA) sales are slowing down, and Moderna stock is going down -- a lot. The coronavirus vaccine maker's shares plunged 21.2% through 10:20 a.m. ET …

nasdaq.com

12%
OFF

What’s Behind The Recent Rise In MRNA Stock? - Forbes

2 weeks from now

Jan 8, 2025 · The stock price of Moderna saw a 12% jump on Tuesday, January 7, amid rising cases of Covid-19 and flu in the U.S. Along with Moderna, stocks of other vaccine makers also …

forbes.com

20%
OFF

Moderna Stock Dropped 20% Last Week. Is It Worth A Look?

2 weeks from now

Oct 7, 2021 · (2% event probability) Moderna’s stock declined -23% over the last ten trading days (two weeks), compared to the broader market (S&P500) which declined by 1.2%; A change of …

nasdaq.com

$1
OFF

Glut Hits Bourbon Producers As Americans Suffer 'Post-Covid …

2 weeks from now

2 days ago · JPMorgan Chase Turns Off Comments After Hundreds Of Employees Speak Out Against Return-To-Office 2 Moderna Stock Poised For Another Drop After Shaving Nearly $1 …

ibtimes.com

$1
OFF

JPMorgan Chase Turns Off Comments After Hundreds Of …

2 weeks from now

2 days ago · Moderna Stock Poised For Another Drop After Shaving Nearly $1 Billion Off Earnings Estimates 4 Lawyer Representing TikTok Warns Ban Could Set Dangerous …

ibtimes.com

20%
OFF

Moderna Stock Dropped 20% Last Week. Is It Worth A Look?

2 weeks from now

Oct 6, 2021 · (2% event probability)Moderna’s stock declined 20% over a five day trading period ending 10/4/2021, compared to the broader market (S&P500) which declined by 3% A change …

forbes.com

FAQs about Moderna Stock Poised For Another Drop After Shaving Nearly $1 … Coupon?

Why did Moderna stock plunge 17% in pre-market trading?

Drug maker Moderna 's stock plunged more than 17% in pre-market trading on Monday after the company slashed its sales outlook by $1 billion. The company reported product sales of $3 to $3.1 billion in 2024 but lowered 2025's expected revenue range to $1.5 to $2.5 billion. ...

Why did Moderna stock fall 52% in 2023?

For perspective, Moderna’s revenue plunged 64% y-o-y to $6.8 billion in 2023 due to lower demand for the Covid-19 vaccine. The company expects its sales to fall to around $3.5 billion in 2024. The company’s latest RSV vaccine is yet to show promising sales. This has weighed on MRNA stock, down 52% since early 2024. ...

Why did Moderna lower its 2025 sales guidance?

Moderna on Monday lowered its 2025 sales guidance by roughly $1 billion due to a few potential headwinds later this year, as the biotech company continues to cut costs and expand its portfolio. Moderna now expects 2025 revenue to come in between $1.5 billion and $2.5 billion, most of which will come in the second half of the year. ...

Why did Moderna stock crash?

Moderna (MRNA) stock crashed Thursday after the Covid vaccine maker slashed its research and development budget by $1.1 billion, issued a light 2025 sales outlook and delayed its breakeven point by two years. The move comes amid a massive commercial push. ...

Why did Moderna stock fall 21%?

Photo: POOL/AFP via Getty Images Moderna Inc.’s stock tumbled 21% Thursday, after the biotech company cut its sales guidance for 2024, offsetting a narrower-than-expected second-quarter loss and revenue that topped estimates. It was the stock’s biggest-ever one-day decline and has erased all of its gains for the year to date. Already a subscriber? ...

Why is Moderna (mRNA) stock plunging?

Moderna (MRNA) stock is plunging Thursday after the COVID-19 vaccine maker announced plans to slash research and development (R&D) expenses and instead focus on receiving approvals for the many drugs in its pipeline. Moderna's plans include a $1.1 billion reduction in R&D expenses by 2027 to a range of $3.6 billion to $3.8 billion. ...